These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 19962740

  • 1. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
    Crépel M, Jeldres C, Perrotte P, Capitanio U, Isbarn H, Shariat SF, Liberman D, Sun M, Lughezzani G, Arjane P, Widmer H, Graefen M, Montorsi F, Patard JJ, Karakiewicz PI.
    Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
    [Abstract] [Full Text] [Related]

  • 2. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M, Jeldres C, Sun M, Lughezzani G, Isbarn H, Alasker A, Capitanio U, Shariat SF, Arjane P, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [Abstract] [Full Text] [Related]

  • 3. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [Abstract] [Full Text] [Related]

  • 4. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.
    Hutterer GC, Patard JJ, Colombel M, Belldegrun AS, Pfister C, Guille F, Artibani W, Montorsi F, Pantuck AJ, Karakiewicz PI.
    Cancer; 2007 Dec 01; 110(11):2428-33. PubMed ID: 17941033
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
    Krambeck A, Iwaszko M, Leibovich B, Cheville J, Frank I, Blute M.
    BJU Int; 2008 Jun 01; 101(11):1375-9. PubMed ID: 18454793
    [Abstract] [Full Text] [Related]

  • 6. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG.
    BJU Int; 2007 Dec 01; 100(6):1235-9. PubMed ID: 17979923
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM.
    BJU Int; 2012 May 01; 109(10):1457-62. PubMed ID: 21933334
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
    Minervini A, Serni S, Giubilei G, Lanzi F, Vittori G, Lapini A, Carini M.
    Eur J Surg Oncol; 2009 May 01; 35(5):521-6. PubMed ID: 18640001
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
    Capitanio U, Perrotte P, Zini L, Jeldres C, Shariat SF, Isbarn H, Arjane P, Peloquin F, Pharand D, Montorsi F, Karakiewicz PI.
    BJU Int; 2009 Sep 01; 104(6):795-9. PubMed ID: 19389018
    [Abstract] [Full Text] [Related]

  • 19. [Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm].
    Boulière F, Crepel M, Bigot P, Pignot G, Bessede T, de la Taille A, Salomon L, Tostain J, Bellec L, Soulié M, Rischmann P, Bernhard JC, Ferrière JM, Pfister C, Albouy B, Colombel M, Zini L, Villers A, Rigaud J, Bouchot O, Patard JJ.
    Prog Urol; 2011 Nov 01; 21(12):842-50. PubMed ID: 22035910
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.